{
    "title": "108_hr2717",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Affordable Medicine Safety and \nAccess Act''.\n\n              TITLE I--INTERNET AND MAIL-ORDER PHARMACIES\n\nSEC. 101. VOLUNTARY CERTIFICATIONS REGARDING INTERNET AND MAIL-ORDER \n              PHARMACIES.\n\n    (a) In General.--Chapter 5 of the Federal Food, Drug, and Cosmetic \nAct (21 U.S.C. 351 et seq.) is amended by inserting after section 503A \nthe following section:\n\n``SEC. 503B. VOLUNTARY CERTIFICATIONS REGARDING INTERNET AND MAIL-ORDER \n              PHARMACIES.\n\n    ``(a) In General.--The Secretary, directly or through contract with \none or more public or nonprofit private entities, shall establish a \nprogram under which Internet and mail-order pharmacies, on a voluntary \nbasis, are certified by the Secretary as meeting the requirements of \nthis section for certification.\n    ``(b) Seal.--The Secretary shall provide for a seal that Internet \nand mail-order pharmacies certified under subsection (a) are authorized \nto display for purposes of indicating to the public the fact of such \ncertification.\n    ``(c) Conditions for Certification.--As a condition of certifying \nan Internet or mail-order pharmacy under subsection (a), the Secretary \nshall require the following with respect to such pharmacy:\n            ``(1) Verification that, in each State in which the \n        pharmacy engages in pharmaceutical activities, the pharmacy, \n        and all the employees and agents of the pharmacy, are in \n        compliance with applicable laws regarding--\n                    ``(A) the practice of pharmacy, including licensing \n                laws; and\n                    ``(B) the manufacturing and distribution of \n                controlled substances, including with respect to \n                mailing or shipping such substances to consumers.\n            ``(2) Controls to ensure that a prescription drug is \n        dispensed by the pharmacy only pursuant to a valid \n        prescription, including circumstance in which the drug is \n        shipped or mailed from a country under whose laws the drug is \n        not a prescription drug.\n            ``(3) The prominent display of contact information for the \n        pharmacy, including a telephone number, an electronic mail \n        address, a mailing address, and (if different from the mailing \n        address) the address for the physical location of the principal \n        place of business of the pharmacy.\n            ``(4) The prominent display of complete and accurate \n        information concerning the ownership and management of the \n        pharmacy, including addresses and contact information.\n            ``(5) A certification from the person who owns or manages \n        the pharmacy that a certification under subsection (a) for the \n        pharmacy has not previously been terminated by the Secretary, \n        and that no other Internet or mail-order pharmacy owned or \n        managed by such person has received a certification under \n        subsection (a) that has been terminated by the Secretary.\n            ``(6) An agreement by the pharmacy that, upon certification \n        under subsection (a), the facilities and business practices of \n        the pharmacy will be subject to inspection by the Secretary to \n        the extent appropriate to determine whether the pharmacy is in \n        compliance with conditions under this subsection.\n            ``(7) Meaningful and accessible opportunities for a \n        consumer to consult with a licensed pharmacist regarding a drug \n        prior to the time at which the pharmacy dispenses the drug to \n        the consumer.\n            ``(8) Controls to ensure that, prior to dispensing a drug \n        to a consumer, a prospective review of the use of the drug by \n        the consumer is completed, based on accurate information about \n        the consumer and the medication profiles of the consumer and \n        other pertinent medical information.\n            ``(9) Effective, accessible systems for communication with \n        consumers, including systems for consumer reporting of adverse \n        drug reactions and errors, systems by which consumers can \n        effectively track and report problems with unfulfilled orders, \n        systems for the investigation and redress of consumer \n        complaints, and systems facilitating effective communication \n        between the pharmacy and consumers concerning drug recalls.\n            ``(10) Controls to ensure the protection of patient privacy \n        and confidentiality, including but not limited to the \n        prevention of unauthorized internal and external use of \n        personally-identifiable patient information.\n            ``(11) An agreement by the pharmacy that the pharmacy will \n        notify the Secretary within 10 days concerning any change in \n        information submitted under this subsection as a condition of \n        certification under subsection (a).\n            ``(12) Such additional criteria as the Secretary \n        determines, after notice and opportunity for comment, to be \n        appropriate for the sound operation of certified pharmacies or \n        the protection of consumers.\n    ``(d) Annual Application; Duration of Certification.--\n            ``(1) In general.--The Secretary may certify an Internet or \n        mail-order pharmacy under subsection (a) only if the pharmacy \n        submits to the Secretary an application for such certification \n        that demonstrates compliance with the conditions under \n        subsection (c) and is in such form, and is made in such manner, \n        as the Secretary may require. The Secretary shall establish an \n        application form for purposes of the preceding sentence, \n        including an electronic application form.\n            ``(2) Duration of certification; renewal.--\n                    ``(A) In general.--A certification under subsection \n                (a) is effective for the one-year period beginning on \n                the date on which the application under paragraph (1) \n                for such certification is approved by the Secretary. \n                The Secretary may renew the certification, pursuant to \n                the submission of an additional application under \n                paragraph (1), and the number of renewals of the \n                certification is not limited. The Secretary may \n                establish an abbreviated process for such renewal \n                applications.\n                    ``(B) Renewal evaluation.--Before renewing a \n                certification under subsection (a), the Secretary shall \n                conduct an evaluation to determine whether the pharmacy \n                involved is in compliance with the conditions under \n                subsection (c). The evaluation, at the Secretary's \n                discretion and as applicable, may include testing of \n                the Internet site of the pharmacy or other systems \n                through which the pharmacy communicates with consumers, \n                and may include physical inspection of the records and \n                premises of the pharmacy pursuant to subsection (c)(6).\n    ``(e) Fees.--The Secretary may impose a fee on the submission of an \napplication under subsection (d). Any such fee is due upon the \nsubmission of the application. To the extent provided in appropriations \nActs, such fees are available to the Secretary for carrying out this \nsection.\n    ``(f) Information Campaign.--The Secretary shall carry out \nactivities to inform the public of the program under subsection (a), \nincluding information on the significance of the seal under subsection \n(b) when displayed by an Internet or mail-order pharmacy, and including \ninformation on the benefits of doing business with a pharmacy certified \nunder subsection (a) as compared to a pharmacy that is not so \ncertified.\n    ``(g) Termination of Certification.--The Secretary, upon the own \ninitiative of the Secretary or a petition by an interested person, may \nterminate a certification under subsection (a), after notice to the \nInternet or mail-order pharmacy involved and an opportunity for a \nhearing.\n    ``(h) Contract for Operation of Program.--\n            ``(1) Determination regarding use of contract authority.--\n        The Secretary may award a contract under subsection (a) for the \n        operation of the program under such subsection only if the \n        Secretary determines that the administration by the contractor \n        of such program would be as protective or more protective of \n        the public than direct administration of the program by the \n        Secretary.\n            ``(2) Certain requirements.--With respect to a contract \n        under subsection (a):\n                    ``(A) The duration of the contract may not exceed \n                two years.\n                    ``(B) The Secretary may renew the contract, subject \n                to compliance with subparagraph (A).\n                    ``(C) The Secretary shall annually review \n                performance under the contract.\n                    ``(D) The contract shall specify that the Secretary \n                may terminate the contract for unsatisfactory \n                performance under the contract.\n    ``(i) Definitions.--For purposes of this section:\n            ``(1) The term `Internet pharmacy' means a pharmacy that, \n        by shipping, mailing, or transporting a prescription drug, \n        dispenses such drug pursuant to a sale of the drug by the \n        pharmacy in circumstances in which the purchaser of the drug \n        submitted the purchase order for the drug, or conducted any \n        other part of the sales transaction for the drug, through an \n        Internet site.\n            ``(2) The term `mail-order pharmacy' means a pharmacy that, \n        by shipping, mailing, or transporting a prescription drug, \n        dispenses such drug pursuant to a sale of the drug by the \n        pharmacy in circumstances in which the purchaser of the drug \n        submitted the purchase order for the drug, or conducted any \n        other part of the sales transaction for the drug, through the \n        mail or through any telecommunications means other than an \n        Internet site.\n            ``(3)(A) Subject to subparagraph (B), the term `pharmacy' \n        means an organization licensed by a State to practice pharmacy, \n        including the dispensing and selling of prescription drugs.\n            ``(B) The Secretary shall consider an organization as \n        meeting the definition established in subparagraph (A) if the \n        Secretary determines that the organization would qualify for \n        licensure in at least one of the States but for a policy of \n        such State that denies licensure as a pharmacy on the basis \n        that the organization dispenses prescription drugs from \n        locations in Canada or dispenses prescription drugs obtained by \n        such organization from an entity in Canada.\n            ``(4) The term `prescription drug' means a drug subject to \n        section 503(b).''.\n    (b) Unauthorized Display of Seal; False Claims.--Section 301 of the \nFederal Food, Drug, and Cosmetic Act (21 U.S.C. 331) is amended by \nadding at the end the following:\n    ``(hh) The display by an Internet or mail-order pharmacy of the \nseal under section 503B without a certification in effect under such \nsection for the pharmacy, or the making by such a pharmacy of a false \nclaim that such a certification is in effect for the pharmacy.''.\n\n    TITLE II--PERSONAL IMPORTATION OF PRESCRIPTION DRUGS FROM CANADA\n\n                     Subtitle A--Waiver Requirement\n\nSEC. 201. WAIVER REQUIREMENT FOR PERSONAL IMPORTATION OF PRESCRIPTION \n              DRUGS FROM CANADA.\n\n    Chapter VIII of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. \n381 et seq.) is amended by adding at the end the following section:\n\n  ``waiver requirement for personal importation of prescription drugs \n                              from canada\n\n    ``Sec. 805. With respect to the importation by individuals of \nprescription drugs from Canada, the Secretary shall in accordance with \nthis section establish by regulation a waiver of prohibitions under \nthis Act that apply to the importation of drugs. Such a waiver shall \npermit an individual to import into the United States any prescription \ndrug that--\n            ``(1) is imported from Canada for personal use by the \n        individual (not for resale);\n            ``(2) is approved by the Secretary under section 505, is \n        manufactured in an establishment registered with the Secretary \n        under section 510, and is not a controlled substance in \n        schedule I, II, or III under section 202(c) of the Controlled \n        Substances Act;\n            ``(3) is imported from a Canadian pharmacy that has \n        submitted to the Secretary a registration that identifies the \n        pharmacy and provides documentation that the pharmacy is \n        licensed in Canada;\n            ``(4) is imported in a quantity that does not (for that \n        instance of importation) exceed a 90-day supply;\n            ``(5) at the time of importation, is accompanied by a copy \n        of a valid prescription for the drug for the individual, issued \n        in the United States by a practitioner in accordance with \n        section 503(b), or is accompanied by documentation that \n        verifies the issuance of such a prescription for the \n        individual;\n            ``(6) is in the form of a final finished dosage; and\n            ``(7) is imported under such other conditions as the \n        Secretary determines to be necessary to ensure public \n        safety.''.\n\n                          Subtitle B--Studies\n\nSEC. 211. STUDY REGARDING IN-PERSON PERSONAL IMPORTATION FROM CANADA.\n\n    (a) In General.--The Secretary of Health and Human Services \n(referred to in this subtitle as the ``Secretary''), acting through the \nCommissioner of Food and Drugs, shall conduct a study for the purpose \nof developing recommendations regarding any legislative or \nadministrative changes that may be necessary to provide reasonable \nassurance concerning the safety and effectiveness of prescription drugs \nthat are purchased in-person at a licensed pharmacy in Canada and \nimported from Canada into the United States for personal use by \nindividuals who are not in the business of importing such drugs \n(referred to in this section with respect to such drugs as ``in-person \npersonal importation''). Not later than 18 months after the date of the \nenactment of this Act, the Secretary shall submit to the Congress a \nreport describing the findings of such study.\n    (b) Certain Requirements.--The activities of the Secretary in \ncarrying out the study under subsection (a) shall include the \nfollowing:\n            (1) With respect to prescription drugs that are commonly \n        purchased from Canadian pharmacies for in-person personal \n        importation, the purchase of a representative sample of such \n        drugs at randomly-selected Canadian pharmacies that are \n        representative of Canadian pharmacies from which prescription \n        drugs are purchased for personal importation.\n            (2) Determining, for purposes of laws and regulations \n        administered by the Food and Drug Administration, the safety \n        and effectiveness of the prescription drugs that are purchased \n        under paragraph (1).\n            (3) Making a comparison of laws and regulations referred to \n        in paragraph (2) with the Canadian system for the regulation of \n        the safety and effectiveness of prescription drugs.\n    (c) Advisory Board.--The Secretary shall establish an advisory \nboard for the purpose of providing advice to the Secretary regarding \nthe design of the study under subsection (a) and regarding the \ndevelopment of recommendations in the study. The membership of the \nadvisory board shall include representatives of the Directorate of \nBorder and Transportation Security (Department of Homeland Security); \nthe comparable agency or agencies of the Canadian government; health \nofficials of State and local governments; pharmacists in the United \nStates; and physicians and patients in the United States.\n\nSEC. 212. STUDY REGARDING INTERNET AND MAIL-ORDER PHARMACIES CLAIMING \n              CANADIAN SOURCES FOR PRESCRIPTION DRUGS.\n\n    With respect to prescription drugs that are commonly prescribed in \nthe United States, the Secretary, acting through the Commissioner of \nFood and Drugs, shall conduct a study through which the Secretary--\n            (1) makes purchases of such drugs from Internet pharmacies \n        and mail-order pharmacies that make sales to consumers in the \n        United States and claim such drugs are obtained from Canadian \n        pharmacies or wholesalers, which purchases are a representative \n        sample of such drugs purchased from such pharmacies; and\n            (2) determines whether the drugs purchased under paragraph \n        (1) are approved for commercial distribution in Canada and are \n        obtained from Canadian pharmacies or wholesalers.\nThe Secretary shall seek the cooperation of the Government of Canada in \nmaking the determination under paragraph (2). Not later than 18 months \nafter the date of the enactment of this Act, the Secretary shall submit \nto the Congress a report describing the findings of such study."
}